Most Recent
Former Slater & Gordon auditor Pitcher Partners has been hit with a class action alleging it signed off on an overly rosy 2015 year-end financial report that failed to disclose risks and impairments the firm faced from its recent acquisition of UK firm Quindell.
BHP Billiton is facing the possibility of a second shareholder class action over the Fundao dam failure at its mine in Brazil, but the cases may be put on hold pending the outcome of homicide charges against company employees.
The alleged masterminds behind the $130 million Plutus Payroll tax fraud have been barred by the Full Federal Court from using insurance to cover their $300,000 legal bill in two criminal proceedings.
Supermarket dessert maker Wicked Sister has brought a trade mark infringement suit against the maker of dipping sauces that this year launched a dessert it branded Wicked Waffle Dippers.
Two 'sham letters' produced by a senior manager of national car repair franchise Ultra Tune led both the ACCC and the court 'down the garden path,' a Federal Court judge heard Thursday.
A conglomerate of entertainment companies, including Roadshow Films, Columbia Pictures and Disney, have launched further court proceedings against Australia's telecommunication giants to block 151 domains accused of facilitating the piracy of copyrighted movies and TV shows.
The Australian Competition and Consumer Commission is reportedly seeking a $10 million fine against H.J. Heinz after a Federal Court found it made misleading claims about the health benefits of its Little Kids Shredz products.
The Australian maker of Difflam has taken UK consumer goods giant Reckitt Benckiser to court over ads for Strepfen that claim the rival lozenges provide 'longer lasting relief' from sore throats.
Chart topper Guy Sebastian has brought a lawsuit against his former manager Titus Day seeking shares in two of Day's companies, which he says he was promised in exchange for sticking with Day as a manager.
The final day of trial in the ACCC's case over muscle gel Voltaren wrapped up Wednesday with a barrister for GlaxoSmithKline slamming as 'onerous' a compliance regime proposed by the consumer watchdog and blasting an injunction as unnecessary for a problem the pharmaceutical giant 'inherited' from Novartis.